You Position: Home > Paper
Optimizing and stratification therapy for adult acute lymphoblastic leukemia
( views:408, downloads:408 )
- Author:
- No author available
- Journal Title:
- JOURNAL OF LEUKEMIA & LYMPHOMA
- Issue:
- 10
- DOI:
- 10.3760/cma.j.issn.1009-9921.2010.10.002
- Key Word:
- 白血病,淋巴细胞,急性;危险分层;治疗;Leukemia,lymphoblastic,acute;Risk stratification;Treatment
Abstract： Unlike children, the outcome of adult acute lymphoblastic leukemia (ALL) has not changed in past decades. There are many risk factors influencing the outcome. The most important factor is the early response to chemotherapy. The outcome of adult ALL is improved when receiving pediatric ALL regimen.Targeting therapy combined with chemotherapy have improved the outcome of Ph+ ALL and ALL expressing CD20+ Allogeneic stem cell transplantation is beneficial to high risk ALL.
- [1]Mihara K,Campana D,Pui CH,etc.Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.[J].2007,117(4).
- [2]Kamps WA,Locatelli F,Basso G,etc.Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia.[J].2005,23(28).
- [3]Bene MC,Hunault M,Guyotat D,etc.Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial.[J].2007,92(12).
- [4]Gaynon P,La M,Sanford B,etc.What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.[J].2008,112(5).
- [5]Hofmann WK,Baldus CD,Gokbuget N,etc.High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults.[J].2006,24(29).
- [6]Slavin S,Rocha V,Tabrizzi R,etc.Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.[J].2008,93(2).
- [7]Cohen HJ,Sallan SE,Silverman LB,etc.Childhood T-cell acute lymphoblastic leukemia: the dana-farber cancer institute acute lymphoblastic leukemia consortium experience.[J].2003,21(19).
- [8]Kager L,Cheok M,Yang W,etc.Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics.[J].2005,115(1).
- [9]Schrauder A,Niggli F,Welte K,etc.Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.[J].2006,24(36).
- [10]Sallan SE,Silverman LB,DeAngelo DJ,etc.Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.[J].2007,25(7).
- [11]Resta DJ,Druker BJ,Sawyers CL,etc.Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.[J].2001,344(14).
- [12]Blume KG,Wong RM,Laport GG,etc.Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen.[J].2008,112(3).
- [13]Tallman MS,Ciobanu N,Richards SM,etc.In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolida[J].2008,111(4).
- [14]Jimenez Velasco A,Prosper F,Roman Gomez J,etc.Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis.[J].2005,23(28).
- [15]Dombret H,Leblanc T,Michel G,etc.Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials.[J].2003,21(5).